These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16832154)

  • 41. Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.
    Nakatsu T; Toyonaga S; Mashima K; Yuki Y; Nishitani A; Ogawa H; Miyoshi T; Hirohata S; Izumi R; Kusachi S
    Clin Drug Investig; 2010; 30(10):699-706. PubMed ID: 20701401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of combination therapy with an L/N-Type Ca(2+) channel blocker, cilnidipine, and an angiotensin II receptor blocker on the blood pressure and heart rate in Japanese hypertensive patients: an observational study conducted in Japan.
    Nagahama S; Norimatsu T; Maki T; Yasuda M; Tanaka S
    Hypertens Res; 2007 Sep; 30(9):815-22. PubMed ID: 18037774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T; Ueno M; Tominaga M; Kajioka T; Onaka U; Eto K; Goto K
    Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
    Yamagishi T
    Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress-induced blood pressure elevation in subjects with mild cognitive impairment: effects of the dual-type calcium channel blocker, cilnidipine.
    Kawashima Y; Akishita M; Hasegawa H; Kozaki K; Toba K
    Geriatr Gerontol Int; 2008 Dec; 8(4):278-83. PubMed ID: 19149840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High morning home blood pressure is associated with a loss of functional independence in the community-dwelling elderly aged 75 years or older.
    Nishinaga M; Takata J; Okumiya K; Matsubayashi K; Ozawa T; Doi Y
    Hypertens Res; 2005 Aug; 28(8):657-63. PubMed ID: 16392770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-pill combination of cilnidipine, an l-/n-type calcium channel blocker, and valsartan reduces the day-by-day variability of morning home systolic blood pressure in patients with treated hypertension: A sub-analysis of the HOPE-combi survey.
    Kario K; Matsuda S; Nagahama S; Kurose Y; Sugii H; Teshima T; Suzuki N
    J Clin Hypertens (Greenwich); 2021 Feb; 23(2):392-397. PubMed ID: 33455076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients: The CA-ATTEND study.
    Aoki S; Hosomi N; Nezu T; Teshima T; Sugii H; Nagahama S; Kurose Y; Maruyama H; Matsumoto M
    Clin Exp Hypertens; 2017; 39(3):225-234. PubMed ID: 28448181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
    Mori H; Yamamoto H; Ukai H; Yuasa S; Nakajima K; Mikawa T; Niizuma M; Hirao K; Umemura S;
    Hypertens Res; 2013 Mar; 36(3):202-7. PubMed ID: 23013888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy.
    Saito I; Suzuki H; Kageyama S; Saruta T
    Clin Exp Hypertens; 2011; 33(5):275-80. PubMed ID: 21787236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population.
    Bombelli M; Fodri D; Toso E; Macchiarulo M; Cairo M; Facchetti R; Dell'Oro R; Grassi G; Mancia G
    Hypertension; 2014 Nov; 64(5):943-50. PubMed ID: 25156170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients.
    Kario K; Ishikawa J; Pickering TG; Hoshide S; Eguchi K; Morinari M; Hoshide Y; Kuroda T; Shimada K
    Hypertens Res; 2006 Aug; 29(8):581-7. PubMed ID: 17137213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of long-term antihypertensive treatment on white-coat hypertension.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    Hypertension; 2014 Dec; 64(6):1388-98. PubMed ID: 25245386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical value of ambulatory blood pressure: evidence and limits.
    Mancia G; Verdecchia P
    Circ Res; 2015 Mar; 116(6):1034-45. PubMed ID: 25767288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.
    Matsui Y; O'Rourke MF; Hoshide S; Ishikawa J; Shimada K; Kario K
    Hypertension; 2012 Jun; 59(6):1132-8. PubMed ID: 22547439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ambulatory blood pressure monitoring in hypertensive CAPD patients].
    Kuriyama S; Tomonari H; Abe A; Kawamura Y; Hosoya T
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):625-31. PubMed ID: 11195398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of Masked Hypertension in Subjects Treated with Antihypertensive Drugs as Assessed by Morning versus Evening Home Blood Pressure Measurements: the J-HOME study.
    Obara T; Ohkubo T; Asayama K; Kikuya M; Metoki H; Inoue R; Komai R; Murai K; Hashimoto J; Totsune K; Imai Y;
    Clin Exp Hypertens; 2008 Apr; 30(3):277-87. PubMed ID: 18425707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.